These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings - Abbott Laboratories (NYSE:ABT)
4 Articles
4 Articles
Abbott Laboratories (NYSE:ABT) Shares Acquired by Mariner LLC
Mariner LLC boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,273,383 shares of the healthcare product maker's stock after acquiring an additional 13,298 shares during t
Stifel Nicolaus Issues Positive Forecast for Abbott Laboratories (NYSE:ABT) Stock Price
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective upped by Stifel Nicolaus from $135.00 to $145.00 in a research report released on Thursday,Benzinga reports. They currently have a buy rating on the healthcare product maker’s stock. Several other brokerages have also weighed in on ABT. StockNews.com lowered shares of Abbott Laboratories from a […]
Abbott Laboratories (NYSE:ABT) Price Target Raised to $159.00 at Barclays
Abbott Laboratories (NYSE:ABT – Get Free Report) had its target price upped by analysts at Barclays from $158.00 to $159.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the healthcare product maker’s stock. Barclays‘s price target suggests a potential upside of 21.53% from […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage